메디아나

041920KOSDAQ

52.4 / 100

Reference Date: 2026-09-08

Financial Score21.0 / 40

News Sentiment18.4 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Declined 7.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Mediana operates in the medical device industry, which is characterized by technology-intensive products and a diverse range of small-batch manufacturing. The company focuses on patient monitoring devices, leveraging growth driven by aging populations and increasing healthcare demand globally.

Number of Employees

179people

Average Salary

45.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

29.72Industry Average 15.001.5Point

2.0x industry avg (risky)

PBR

1.17Industry Average 1.204.0Point

In line with industry avg

ROE

4.01Industry Average 8.002.5Point

Below industry avg

Debt Ratio

0.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼6.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲134.2% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.3% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 73.8

Neutral
셀바스헬스케어, 충남대학교와 산학협력 업무협약 체결
메디아나 관련 직접적인 영향 없음: 충남대학교와의 산학협력 협약은 셀바스헬스케어에 긍정적이나 메디아나 주식에 직접적인 영향은 제한적.
Positive
메디아나, 하반기 실적 퀀텀점프… ECG·의료 AI 매출 본격 인식
메디아나의 하반기 실적이 ECG 및 의료 AI 신사업의 본격적인 매출 인식으로 인해 크게 상승할 것으로 예상되어 긍정적 전망이 강화되었다.
Positive
씨어스, 1000원에 팔아 440원 남겼다...제약바이오·헬스케어 '수...
씨어스의 높은 수익성으로 제약바이오 및 헬스케어 분야에서의 경쟁력이 강화되고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 8,500Won52-week high 28,65052-week low 4,870

1-month return1.0Point

1m -7.91% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14